Document Detail

Is lead mobilised by cisplatin?
MedLine Citation:
PMID:  2569135     Owner:  NLM     Status:  MEDLINE    
P Tothill; L M Matheson; K McKay; J F Smyth
Related Documents :
17644875 - Safety of erythropoiesis stimulating agents in patients on dialysis: current issues for...
15819825 - Colour and translucency of opaque-shades and body-shades of resin composites.
18832195 - Invited review: crossbreeding in dairy cattle from a german perspective of the past and...
2927635 - A directional bias for studies of laterality.
9044005 - The impact of the commissioning agenda upon nursing practice: a proactive approach to i...
12673985 - A model for clinical practice within the consultant nurse role.
Publication Detail:
Type:  Comment; Letter    
Journal Detail:
Title:  Lancet     Volume:  2     ISSN:  0140-6736     ISO Abbreviation:  Lancet     Publication Date:  1989 Aug 
Date Detail:
Created Date:  1989-09-01     Completed Date:  1989-09-01     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985213R     Medline TA:  Lancet     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  333     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cisplatin / pharmacology*,  therapeutic use
Kidney / metabolism*
Lead / metabolism*,  urine
Middle Aged
Reg. No./Substance:
15663-27-1/Cisplatin; 7439-92-1/Lead
Comment On:
Lancet. 1986 Aug 2;2(8501):249-50   [PMID:  2874280 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Are diarrhoea control programmes likely to reduce childhood malnutrition? Observations from rural Ba...
Next Document:  Determination of ethane and pentane in free oxygen radical-induced lipid peroxidation.